|
Felise Cooper
Associate
Allen & Overy LLP
|
Qualifications:
J.D., Columbia Law School, Harlan Fiske Stone Scholar 2003
B.A., Northwestern University, magna cum laude and departmental honors 1998
Post Qualification Experience:
Associate, Allen & Overy LLP, New York May 2005–present
Associate, Cravath, Swaine & Moore LLP, New York Sept. 2003–May 2005
Relevant Experience:
Felise Cooper, based in New York, is an associate in the U.S. Environmental and Regulatory Law Group of Allen & Overy LLP. She advises U.S. and multinational clients on environmental issues in business transactions and counsels on compliance requirements, including compliance with U.S. and European Union substance disclosure, control and take-back requirements. Felise recently spoke on product regulation issues at events hosted by NEDA, iNEMI and IPC, as well as at several AeA high-tech and e-waste seminars; she has also spoken on regulatory issues affecting the health and beauty industry at the HBA Regulatory Summit. Felise has extensive experience advising on environmental risk in transactions, managing due diligence and coordinating work by technical consultants. Previously, Felise was an associate at Cravath, Swaine & Moore LLP in New York, an intern at New York Lawyers for the Public Interest, Inc. and, prior to law school, a legal assistant in the environmental group at Cravath, Swaine & Moore. At Columbia Law School, she was a Harlan Fiske Stone Scholar, a teaching assistant for Negotiation Workshop, a member of the Clinic on Non-profit Organizations and Small Businesses, and a co-founder of Columbia Law School Yoga Club.
Representative Engagements:
- Various U.S. and multi-national computer equipment and other high-tech product manufacturers and distributors—ongoing advice regarding compliance with EU environmental directives, including the WEEE and RoHS Directives
- GE Healthcare—representation in its acquisition of IDX Corporation, a leading provider of medical information technology systems, for $1.2 billion
- Several multi-national military systems, defense and aerospace companies—representation in sales of U.S.-based manufacturing divisions
- A multi-national medical device company—representation in its acquisition of a U.S.-based urology and gynecology endoscopy company for approximately $500 million
This page was last updated on 03/02/07.
Copyright © 2006 American Electronics Association. All rights reserved.
|